Cited by 460Alzheimer's disease research and treatmentsNuclear Structure and FunctionAmyotrophic Lateral Sclerosis Research

Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer’s Disease

Open access
Eftekharzadeh, Bahareh, Daigle, J. Gavin, Kapinos, Larisa E., Coyne, Alyssa, Schiantarelli, Julia, Carlomagno, Yari, Cook, Casey, Miller, Sean J. +22 more·2018·Neuron

Abstract

Tau is the major constituent of neurofibrillary tangles in Alzheimer's disease (AD), but the mechanism underlying tau-associated neural damage remains unclear. Here, we show that tau can directly interact with nucleoporins of the nuclear pore complex (NPC) and affect their structural and functional integrity. Pathological tau impairs nuclear import and export in tau-overexpressing transgenic mice and in human AD brain tissue. Furthermore, the nucleoporin Nup98 accumulates in the cell bodies of some tangle-bearing neurons and can facilitate tau aggregation in vitro. These data support the hypothesis that tau can directly interact with NPC components, leading to their mislocalization and consequent disruption of NPC function. This raises the possibility that NPC dysfunction contributes to tau-induced neurotoxicity in AD and tauopathies.

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2018.07.039

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In vitro studies using soluble phospho-tau oligomers find substantial alterations in nuclear-cytoplasmic transport.

    “Not only is there clear morphological evidence of nuclear alterations in AD, but also, in vitro studies using soluble phospho-tau oligomers as a perturbant find substantial alterations in nuclear–cytoplasmic transport (e.g., 31, 33, 37, 54).”

    From All the Tau We Cannot See (2023) · cites this paper as [33]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Eftekharzadeh, B., Daigle, J. G., Kapinos, L. E., Coyne, A., Schiantarelli, J., Carlomagno, Y., Cook, C., Miller, S. J., Dujardin, S., Amaral, A. S., Grima, J. C., Bennett, R. E., Tepper, K., DeTure, M., Vanderburg, C. R., Corjuc, B. T., DeVos, S. L., Gonzalez, J. A., Chew, J., Vidensky, S., Gage, F. H., Mertens, J., Troncoso, J., Mandelkow, E., Salvatella, X., Lim, R. Y. H., Petrucelli, L., Wegmann, S., Rothstein, J. D., & Hyman, B. T.
Affiliations
  • Harvard University (US)
  • Johns Hopkins University (US)
  • University of Basel (CH)
  • Mayo Clinic (US)
  • Salk Institute for Biological Studies (US)
  • Institute for Research in Biomedicine (ES)
Corresponding author
  • Rothstein, Jeffrey D.
  • Hyman, Bradley T.
Venue
Neuron
Publisher
Elsevier BV
Published
2018-09
Volume
99
Issue
5
Pages
925-940.e7
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2806036204
Cited by
460
References
90
Citations by year
2026: 41 · 2025: 45 · 2024: 67 · 2023: 57 · 2022: 61 · 2021: 66 · 2020: 75 · 2019: 37 · 2018: 11
FWCI
32.42
Type
journal article
Language
en
Update notices
erratum (2019-01-16)
Open access
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • edoc (University of Basel) (submittedVersion)
  • DZNE Pub (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • NIH (P01NS099114, R01NS094239, R01NS099320)
  • ADRC (2 P50AG016574, U54NS100693, R35NS097273, P01NS084974, R01NS089544, R21NS094489, R01AG056306)
  • Massachusetts Alzheimer Disease Research Center (P50AG005134)
  • JPB Foundation
  • Swiss National Science Foundation (31003A_170041)
  • Paul G. Allen Family Foundation
  • Glenn Foundation Center for Aging Research
  • American Federation for Aging Research
  • Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002)
  • Annette Merle-Smith
  • Mathers Foundation
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
tau protein, Alzheimer's disease, nuclear transport, nuclear pore complex, nucleoporins, NUP98, nuclear import, nuclear export, neurofibrillary tangles, tau aggregation, tauopathy, neurotoxicity
MeSH terms
Alzheimer Disease, Animals, Cell Nucleus, Cytoplasm, Female, Humans, Male, Mice, Transgenic, tau Proteins, Active Transport, Cell Nucleus, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review